Mark Clein

Mark P.
Clein is the founder of Precision For Medicine, Inc. (2012), United BioSource Corp.
(2003), Precision AQ (2012), and Precision Medicine Group LLC (2012).
Titles held included Executive Chairman at Precision AQ and Precision Medicine Group LLC, and President at United BioSource Corp.
Current jobs include Director at MetaWorks, Inc., President & Director at PRECISIONeffect, Inc., Co-Managing Director at Precision For Medicine GmbH, Director at Precision Medicine Group Holdings, Inc., Director at Precision for Medicine & Oncology (UK) Ltd., Director at Precision for Medicine & Oncology Holdings (UK) Ltd. since 2017, and Director at Precision Effect Europe Ltd. since 2018.
Former jobs include Chief Executive Officer & Director at Psychiatric Solutions, Inc. (1999-2002), Chief Executive Officer at PMR Corp.
(1999-2002), Managing Director at Rodman & Renshaw, Inc. (1995), Managing Director-Health Care Investment Banking at Jefferies LLC (1999), Managing Director at Mabon Securities Corp.
(1995), Vice President at Sprout Group (1993), Chief Financial Officer & Executive Vice President at US Bioservices Corp.
(2002-2003), Vice President & Partner at Merrill Lynch Venture Capital, Inc. (1991), Partner at LCI Partners (2003), and Vice President & Partner at Merrill Lynch Venture Capital, Inc. (1982-1990).
Education includes an MBA from The Trustees of Columbia University in The City of New York and an undergraduate degree from The University of North Carolina at Charlotte.